Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 I
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- DOE - Office Of Science; NCI; National Institutes of Health (NIH)
- OSTI ID:
- 1787774
- Journal Information:
- J. Med. Chem., Vol. 64, Issue (9)
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 I
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor
Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling
Journal Article
·
2021
· J. Med. Chem.
·
OSTI ID:1784971
+12 more
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor
Journal Article
·
2016
· Journal of Medicinal Chemistry
·
OSTI ID:1354334
+17 more
Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling
Journal Article
·
2017
· MedChemComm
·
OSTI ID:1357628
+24 more